Business Wire - MabCure Receives U$500,000.00 Licensing Fee as Well as 12.5% Ongoing Royalty for Its Prostate Cancer Diagnostic Technology

November 22, 2011 --

NEW YORK -- MabCure, Inc. (OTCBB: MBCI), a leading developer of antibody-based diagnostics and treatments for ovarian and prostate...

PR Newswire - Molecular Devices, LLC Introduces SoftMax Pro 6 Microplate Data Acquisition and Analysis Software With Powerful New Data Analysis and Reporting Features

October 27, 2011 --

SUNNYVALE, Calif., Oct. 27, 2011 /PRNewswire/ -- Today, Molecular Devices, LLC, a leader in bioanalytical systems for drug discovery, life...

Market Wire - Advanced Cell Technology's Chief Medical Officer Featured on National Radio Show About Biotech Breakthroughs

December 1, 2010 --

Dr. Robert Lanza, the Chief Scientific Officer of Advanced Cell Technology (OTCBB: ACTC) was featured and interviewed as "one of the leading...

MondayMorning - Ex ImClone CEO Waksal back to Biotech with Deal

November 1, 2010 --

Ex ImClone CEO Waksal Back to Biotech with Deal. Sam Waksal, the former chief executive of ImClone Systems Inc. (New York), whose insider...

Market Wire - Kane Biotech Develops DispersinB(R) Monoclonal Antibodies

September 21, 2010 --

Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and...

Market Wire - News From BIO Annual Convention

May 21, 2009 --

The Biotechnology Industry Organization's annual convention in Atlanta drew 20,000 scientists, industry leaders and government officials who...

National Catholic Reporter - Biotechnology: with new document, Vatican extends pro-life agenda

December 26, 2008 -- [ILLUSTRATION OMITTED]

[ILLUSTRATION OMITTED]

In a resounding confirmation that the Catholic church's pro-life concern extends to the...

Business Wire - Cellectis BioResearch, a Subsidiary of Cellectis S.A., Announces the Market Launch of a First Revolutionary Research Kit

December 1, 2008 -- Considerable Time Savings in the Development of Stable Cell Clones

Considerable Time Savings in the Development of Stable Cell Clones

...

Chemistry and Industry - Lilly acquires ImClone for $6.5bn

October 13, 2008 -- US pharma major Eli Lilly is acquiring US biopharmaceutical specialist ImClone Systems for $70/share.

US pharma major Eli Lilly is acquiring...

MondayMorning - Lilly Outbids Bristol-Myers for ImClone

October 13, 2008 -- Lilly Outbids Bristol-Myers for ImClone. Eli Lilly & Co. (Indianapolis IN) agreed to acquire ImClone Systems Inc. (New York) for $6.5 billion,...

Source: